Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol. 2002 Mar 18;156(6):1051-63. PubMed Abstract, View on AlzSWAN


Corresponding Author: Dr. Eva-Maria Mandelkow
  
Comments on Related Papers
  Related Paper: Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles.

Comment by:  Hiroshi Mori, ARF Advisor
Permalink

A view is provided in living cells with and without exogenously transfected tau. It is interesting to see a mechanism for how kinesin attachs or detachs on microtubules with the aid of tau.

View all comments by Hiroshi Mori

  Related Paper: Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure.

Comment by:  Peter Davies
Permalink
  I recommend this paper

"This paper continues the Mandelkow's fine work trying to unravel the mechanism of PHF formation by in vitro studies of structural changes that occur in tau on aggregation. Their identification of regions of tau that seem to be important for aggregation through beta-sheet formation is probably relevant to the mechanism of PHF formation in AD. They are the only group (to my knowledge) to be able to show formation of true paired helical filament structures using mutant tau constructs. Although this is a rather esoteric point, there is some debate about whether neuronal death in the tau mutation cases involves PHF formation as a necessary step. In one of the mutations they use in their study, P301L, the human disease does not appear to involve extensive PHF formation. The Mandelkows discuss the possible mechanisms of cell death in tau mutation cases at some length, and it is clear that in most cases, more than one mechanism might participate in killing cells. However, these mechanistic studies point to important hypotheses that can be tested in cellular and perhaps animal models....  Read more
  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:

Studied neuron-like cell models (N2a neuroblastoma), cultured primary cortical neurons from rats or mice, and chicken retinal ganglion cells (RGCs) for the effects of tau overexpression. An N2a neuroblastoma cell line stably transfected with APP695 was provided by Drs. G. Thinakaran and S. Sisodia (University of Chicago, Chicago, IL).

Antibodies used in this study were rat monoclonal anti-tubulin YL1 (serotec), mouse monoclonal antibody DM1A (Sigma-Aldrich), polyclonal rabbit anti-tau antibody K9JA (Dako), and polyclonal rabbit anti-PMP69 antibody for peroxisomes (gift from Dr. W. Just, University of Heidelberg, Heidelberg, Germany). The monoclonal mouse antibody SMI32 (Sternberger) was used for the detection of unphosphorylated neurofilaments. The monoclonal tag antibodies from mouse against HA tag (12CA5) and myc tag were obtained from Roche Diagnostics and Invitrogen. Polyclonal anti-APP B5 (5313), (residues 444–592) was a gift from Dr. C. Haass (University of München, München, Germany), and monoclonal antibody 6E10 was from Senetek (now produced by Signet).

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad